List of Excipients in API levocetirizine dihydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing levocetirizine dihydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Chattem Inc | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | 41167-3510 | CELLULOSE, MICROCRYSTALLINE | |
| Chattem Inc | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | 41167-3510 | HYPROMELLOSES | |
| Chattem Inc | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | 41167-3510 | LACTOSE MONOHYDRATE | |
| Chattem Inc | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | 41167-3510 | MAGNESIUM STEARATE | |
| Chattem Inc | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | 41167-3510 | POLYETHYLENE GLYCOL 400 | |
| Chattem Inc | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | 41167-3510 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing levocetirizine dihydrochloride
Detailed excipient profiles for levocetirizine dihydrochloride
Excipient focus: ACETIC ACID
levocetirizine dihydrochloride drug variants containing ACETIC ACID
levocetirizine dihydrochloride drug variants not containing ACETIC ACID
Excipient focus: ANHYDROUS LACTOSE
levocetirizine dihydrochloride drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | levocetirizine dihydrochloride | 33261-947 |
| >Company | >Ingredient | >NDC |
levocetirizine dihydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
levocetirizine dihydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
levocetirizine dihydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
levocetirizine dihydrochloride drug variants containing CROSCARMELLOSE SODIUM
levocetirizine dihydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: GLYCERIN
levocetirizine dihydrochloride drug variants containing GLYCERIN
levocetirizine dihydrochloride drug variants not containing GLYCERIN
Excipient focus: HYDROXYPROPYL CELLULOSE
levocetirizine dihydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
levocetirizine dihydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
levocetirizine dihydrochloride drug variants containing HYPROMELLOSE
levocetirizine dihydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
levocetirizine dihydrochloride drug variants containing HYPROMELLOSE 2910
levocetirizine dihydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
levocetirizine dihydrochloride drug variants containing HYPROMELLOSES
levocetirizine dihydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
levocetirizine dihydrochloride drug variants containing LACTOSE MONOHYDRATE
levocetirizine dihydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
levocetirizine dihydrochloride drug variants containing MAGNESIUM STEARATE
levocetirizine dihydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTITOL
levocetirizine dihydrochloride drug variants containing MALTITOL
levocetirizine dihydrochloride drug variants not containing MALTITOL
Excipient focus: METHYLPARABEN
levocetirizine dihydrochloride drug variants containing METHYLPARABEN
levocetirizine dihydrochloride drug variants not containing METHYLPARABEN
Excipient focus: POLYETHYLENE GLYCOL
levocetirizine dihydrochloride drug variants containing POLYETHYLENE GLYCOL
levocetirizine dihydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
levocetirizine dihydrochloride drug variants containing POLYETHYLENE GLYCOL 400
levocetirizine dihydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
levocetirizine dihydrochloride drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | levocetirizine dihydrochloride | 43063-831 |
| A-S Medication Solutions | levocetirizine dihydrochloride | 50090-2591 |
| Apotex Corp | levocetirizine dihydrochloride | 60505-3713 |
| Bryant Ranch Prepack | levocetirizine dihydrochloride | 71335-0162 |
| >Company | >Ingredient | >NDC |
levocetirizine dihydrochloride drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
levocetirizine dihydrochloride drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | levocetirizine dihydrochloride | 33261-947 |
| Aidarex Pharmaceuticals LLC | levocetirizine dihydrochloride | 53217-375 |
| >Company | >Ingredient | >NDC |
levocetirizine dihydrochloride drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
levocetirizine dihydrochloride drug variants containing POLYSORBATE 80
levocetirizine dihydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLPARABEN
levocetirizine dihydrochloride drug variants containing PROPYLPARABEN
levocetirizine dihydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN
levocetirizine dihydrochloride drug variants containing SACCHARIN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | levocetirizine dihydrochloride | 45802-680 |
| Bryant Ranch Prepack | levocetirizine dihydrochloride | 63629-2533 |
| Bryant Ranch Prepack | levocetirizine dihydrochloride | 72162-1424 |
| >Company | >Ingredient | >NDC |
levocetirizine dihydrochloride drug variants not containing SACCHARIN
Excipient focus: SACCHARIN SODIUM
levocetirizine dihydrochloride drug variants containing SACCHARIN SODIUM
levocetirizine dihydrochloride drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
levocetirizine dihydrochloride drug variants containing SILICON DIOXIDE
levocetirizine dihydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM ACETATE
levocetirizine dihydrochloride drug variants containing SODIUM ACETATE
levocetirizine dihydrochloride drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM ACETATE ANHYDROUS
levocetirizine dihydrochloride drug variants containing SODIUM ACETATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA inc | levocetirizine dihydrochloride | 51672-4161 |
| >Company | >Ingredient | >NDC |
levocetirizine dihydrochloride drug variants not containing SODIUM ACETATE ANHYDROUS
Excipient focus: SUCRALOSE
levocetirizine dihydrochloride drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | levocetirizine dihydrochloride | 0527-1917 |
| Taro Pharmaceuticals USA inc | levocetirizine dihydrochloride | 51672-4161 |
| Chartwell RX LLC | levocetirizine dihydrochloride | 62135-917 |
| >Company | >Ingredient | >NDC |
levocetirizine dihydrochloride drug variants not containing SUCRALOSE
Excipient focus: TITANIUM DIOXIDE
levocetirizine dihydrochloride drug variants containing TITANIUM DIOXIDE
levocetirizine dihydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
levocetirizine dihydrochloride drug variants containing WATER
levocetirizine dihydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
